STUDY COMPARING EFFICACY AND SAFETY OF MYCOPHENOLATE MOFETIL (CELLCEPT) WITH DELAYED INTRODUCTION OF SIROLIMUS AND DISCONTINUATION OF CYCLOSPORINE, WITH THOSE OF MYCOPHENOLATE MOFETIL AND LONG TERM CONTINUATION OF CYCLOSPORINE IN RENAL TRANSPLANT RECIPIENTS: